Clinical Trial Update: VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer

View source ↗

Summary

Clinical trial update suggests VEGF receptor status may predict benefit from bevacizumab in advanced non-small cell lung cancer, including patients with brain m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Li Liu | Conditions: Non Small Cell Lung Cancer, Brain Metastasis | Status: UNKNOWN